Guggenheim Capital LLC Siga Technologies Inc Transaction History

Guggenheim Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Jun 02, 2020	SELL	$3.99 - $5.46 $53,709 - $73,497	-13,461 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$4.34 - $5.86 $724 - $978	-167 Reduced 1.23%	13,461 $64,000
Q3 2019 Nov 14, 2019	SELL	$4.93 - $5.8 $3,372 - $3,967	-684 Reduced 4.78%	13,628 $70,000
Q2 2019 Aug 14, 2019	SELL	$5.22 - $6.1 $1,706 - $1,994	-327 Reduced 2.23%	14,312 $82,000
Q1 2019 May 15, 2019	BUY	$5.66 - $7.89 $82,856 - $115,501	14,639 New	14,639 $88,000

166

33.8M

353K

853K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $509M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.